An open-label phase 1 trial of lenvatinib plus pembrolizumab in patients with advanced selected solid tumors

Shigehisa Kitano; Yutaka Fujiwara; Toshio Shimizu; Satoru Iwasa; Kan Yonemori; Shunsuke Kondo; Akihiko Shimomura; Takafumi Koyama; Takahiro Ebata; Sakura Iizumi

doi:10.1093/annonc/mdy375.070

An open-label phase 1 trial of lenvatinib plus pembrolizumab in patients with advanced selected solid tumors

NobleID: NI6P96W25R79S92
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/B2CB42EC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B2CB42EC.svg?ark=w1%2F20260515%2FB2CB42EC&value=id)](https://nobleid.org/work/w1/20260515/B2CB42EC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

An open-label phase 1 trial of lenvatinib plus pembrolizumab in patients with advanced selected solid tumors

NobleID: NI6P96W25R79S92
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/B2CB42EC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B2CB42EC.svg?ark=w1%2F20260515%2FB2CB42EC&value=id)](https://nobleid.org/work/w1/20260515/B2CB42EC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work